Packages (Simulation)
![Multiplex Assay Kit for Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay)](/upload/static/product/LM.jpg)
Reagent Preparation
![Multiplex Assay Kit for Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay)](/upload/static/reagent/TLMB.jpg)
Image (I)
Image (II)
Certificate
![Certificate](/upload/static/ISO13485.jpg)
![Certificate](/upload/static/ce-1.jpg)
Multiplex Assay Kit for Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay)
CXCL10; C7; IFI10; INP10; SCYB10; Crg2; GIP10; Mob1; Chemokine C-X-C Motif Ligand 10; Small Inducible Cytokine Subfamily B(Cys-X-Cys)Member 10
(Note: Up to 8-plex in one testing reaction)
- Product No.LMA371Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3.5h
- Detection Range0.98-1000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.327 pg/mL.
- DownloadInstruction Manual
- UOM 8Plex 7Plex 6Plex 5Plex 4Plex 3Plex 2Plex1Plex
- FOB
US$ 348
US$ 362
US$ 382
US$ 409
US$ 436
US$ 476
US$ 536
Result
For more details, please contact local distributors! US$ 670 Add to Price Calculator
Specificity
This assay has high sensitivity and excellent specificity for detection of Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 95-105 | 101 |
EDTA plasma(n=5) | 83-99 | 94 |
heparin plasma(n=5) | 86-94 | 89 |
sodium citrate plasma(n=5) | 98-105 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Interferon Gamma Induced Protein 10kDa (IP10) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 97-104% | 96-105% | 78-101% | 86-96% |
EDTA plasma(n=5) | 93-105% | 79-101% | 78-104% | 89-96% |
heparin plasma(n=5) | 88-96% | 80-94% | 86-96% | 78-90% |
sodium citrate plasma(n=5) | 78-101% | 93-101% | 90-97% | 82-98% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:IP10) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
20 | Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. PubMed: 22288937 |
BMC Pregnancy and Childbirth | Maternal circulating leukocytes display early chemotactic responsiveness during late gestation PubMed: PMC3561147 |
Rheumatology International | Serum levels of selected chemokines in systemic lupus erythematosus patients Pubmed: 22461186 |
PLOS ONE | The Immunosuppressant Protosappanin A Diminished Recipient T Cell Migration into Allograft via Inhibition of IP-10 in Rat Heart Transplant Pubmed:24798458 |
Front Pharmacol | The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway PubMed: 26696888 |
Cytokine | Hypoxia/ischemia promotes CXCL10 expression in cardiac microvascular endothelial cells by NFkB activation Pubmed:26891076 |
Journal of Experimental & Clinical Cancer Research | LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4. pubmed:28641579 |
Journal of Geriatric Oncology | Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors Pubmed: 30952517 |
Hepatology | Integrated Omics Reveals Tollip as an Aggravator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice Pubmed: 31077413 |
Molecular Medicine Reports | IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer Pubmed: 31173199 |
JOURNAL OF MOLECULAR NEUROSCIENCE | Inflammatory Responses of Astrocytes Are Independent from Lipocalin 2 Pubmed: 32959226 |